ANKRD20A12P: A Drug Target / Disease Biomarker (G100874392)

Target Name: ANKRD20A12P

NCBI ID: G100874392

ANKRD20A12P

Other Name(s): ankyrin repeat domain 20 family member A12, pseudogene | Ankyrin repeat domain 20 family member A12, pseudogene

ANKRD20A12P: A Drug Target / Disease Biomarker

ANKRD20A12P is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the ANKRD2 family of proteins, which are involved in the regulation of actinin cytoskeleton organization and dynamics. The ANKRD20A12P protein is unique due to its unique structure and function.

The ANKRD20A12P protein is composed of 20 different amino acid residues. It has a distinct N-terminus that is involved in the formation of a dimeric complex with the related protein ANKRD20A11P. This dimerization event is critical for the protein's activity and stability. The N-terminus of ANKRD20A12P contains a unique domain that is involved in the regulation of actinin cytoskeleton organization and dynamics.

The ANKRD20A12P protein is involved in the regulation of actinin cytoskeleton organization and dynamics. It plays a role in the formation of the actinin filament, which is the protein subunit that makes up the cytoskeleton. The ANKRD20A12P protein helps to regulate the formation and stability of the actinin filament by interacting with the related protein ANKRD20A11P.

The ANKRD20A12P protein is also involved in the regulation of cell signaling pathways. It has been shown to play a role in the regulation of neurotransmitter signaling, particularly in the regulation of dopamine signaling. The ANKRD20A12P protein has been shown to interact with the neurotransmitter receptors Dopamine and Serotonin, and it has been shown to regulate the release of these neurotransmitters from the axon terminal of neurons.

The ANKRD20A12P protein is also involved in the regulation of cell survival and proliferation. It has been shown to play a role in the regulation of cell cycle progression, and it has been shown to contribute to the maintenance of stem cell properties. The ANKRD20A12P protein helps to regulate the entry of stem cells into the cell cycle by interacting with the related protein p21.

The ANKRD20A12P protein is also involved in the regulation of tissue repair and regeneration. It has been shown to play a role in the regulation of wound healing, and it has been shown to contribute to the formation of new tissues during the process of regeneration. The ANKRD20A12P protein helps to regulate the formation of new tissues by interacting with the related protein transforming growth factor beta (TGF-β).

The ANKRD20A12P protein is also involved in the regulation of inflammation and immune responses. It has been shown to play a role in the regulation of inflammation and immune responses, and it has been shown to contribute to the development of cancer. The ANKRD20A12P protein helps to regulate the formation of immune cells by interacting with the related protein PDGF-1.

In conclusion, ANKRD20A12P is a unique protein that is involved in the regulation of actinin cytoskeleton organization and dynamics, cell signaling pathways, cell survival and proliferation, tissue repair and regeneration, and inflammation and immune responses. Its unique structure and function make it an attractive drug target and biomarker for future research. Further studies are needed to fully understand the role of ANKRD20A12P in the regulation of actinin cytoskeleton organization and dynamics, and to determine its potential as a drug

Protein Name: Ankyrin Repeat Domain 20 Family Member A12, Pseudogene

The "ANKRD20A12P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD20A12P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets